| Value | ₹300.0 Cr |
|---|
BSE filing, NSE: ANTELOPUS. Summary written from the filing by ALFA Finder's alert engine.
Antelopus Selan Energy Ltd: key numbers
- Share price
- ₹1,027.60
- Market cap
- ₹3,631 Cr
- Revenue (annual)
- ₹278.9 Cr
- Net profit (annual)
- ₹89.61 Cr
- P/E (TTM)
- 20.4×Sector 17.8×
- Promoter holding
- 69.69%-0.25% QoQ
- FII holding
- 0.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Antelopus Selan Energy Ltd
All →Antelopus Selan Energy Earnings Call Transcript: Key Takeaways
Management is banking on production ramp-up from Bakrol and Karjisan to reach 2,500 BOEPD exit rate, despite a flat QoQ volume performance and volatility in realized crude prices.
Antelopus Selan Energy Investor Presentation: Key Takeaways
Q2 FY27 net revenue ₹119.1 Cr (+116% YoY), EBITDA ₹90.0 Cr, PAT ₹57.3 Cr (+386% YoY). Average production 1,656 boepd; targets 2,500 boepd FY27 exit.
Antelopus Selan Energy Q2 FY27 Results: Net Profit ₹57.3 Cr, Up 385.6% YoY
Antelopus Selan Energy Ltd reported revenue from operations of ₹119.1 Cr (+116.2% YoY) and net profit of ₹57.3 Cr (+385.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹57.3 Cr · +385.6% YoY
Antelopus Selan Energy Board Meeting Date
Antelopus Selan Energy has scheduled its Board meeting for October 26, 2026 to approve Q1 and H1 FY27 unaudited results. The trading window stays closed until October 28, 2026.
Antelopus Selan Energy Employee Stock Options
Antelopus Selan Energy Limited allotted 51,530 equity shares upon the exercise of options under the Company's Employees Stock Option Scheme – 2022.
Antelopus Selan Energy Other Announcement
Antelopus Selan Energy Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a periodic compliance disclosure.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.